Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

NCT02897050 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: Capecitabine
DRUG: Cyclophosphamide (tablet)
DRUG: Fluorouracil
DRUG: Epirubicin
DRUG: Cyclophosphamide (injection)

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University